Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV, Combination Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00000791
What this trial is testing

A Phase II Double-Blind Study of Two Doses of SC-49483 in Combination With Zidovudine (ZDV) Versus ZDV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 210
Testing effectiveness (Phase 2)Looking for participantsNCT04303117
What this trial is testing

PDS01ADC Monotherapy and in Combination With M7824 in Advanced Kaposi Sarcoma

Who this might be right for
Kaposi Sarcoma
National Cancer Institute (NCI) 80
Not applicableStudy completedNCT00000896
What this trial is testing

Compare the Effectiveness of a Four Drug Anti-HIV Regimen Given Alone or in Combination With GM-CSF or IL-12 to HIV-Positive Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24
Not applicableStudy completedNCT00002108
What this trial is testing

3TC (Lamivudine; GR109714X) Open-Label Program

Who this might be right for
HIV Infections
Glaxo Wellcome
Testing effectiveness (Phase 2)Study completedNCT00002086
What this trial is testing

Trial to Evaluate the Safety and Efficacy of Combination Therapy With Retrovir ( AZT ) and HIVID ( ddC ) Versus Retrovir, HIVID, and Wellferon ( Interferon Alfa-n1 ) for the Treatment of HIV Infection

Who this might be right for
HIV Infections
Glaxo Wellcome 256
Testing effectiveness (Phase 2)Study completedNCT00903682
What this trial is testing

A Clinical Trial Comparing the Tolerability of Etravirine to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Treatment-naive HIV-1 Infected Patients

Who this might be right for
HIV InfectionHIVAcquired Immunodeficiency Syndrome
Janssen-Cilag International NV 157
Not applicableStudy completedNCT00000703
What this trial is testing

Chemotherapy and Azidothymidine, With or Without Radiotherapy, for High Grade Lymphoma in AIDS-Risk Group Members

Who this might be right for
Lymphoma, Non-HodgkinHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 45
Large-scale testing (Phase 3)Study completedNCT00234910
What this trial is testing

Efficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standard of Care Regimen in Treatment naïve HIV Infected Patients

Who this might be right for
HIV Infection
Abbott 152
Not applicableStudy completedNCT03307226
What this trial is testing

Suubi4Her: Combination Intervention for Adolescent Girls Transitioning Into Adulthood in Uganda

Who this might be right for
HIV/AIDS
Washington University School of Medicine 1,260
Not applicableStudy completedNCT00000717
What this trial is testing

The Safety and Efficacy of Clindamycin and Primaquine in the Treatment of Mild - Moderate Pneumocystis Carinii Pneumonia in Patients With AIDS

Who this might be right for
Pneumonia, Pneumocystis CariniiHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 50
Large-scale testing (Phase 3)Study completedNCT00543725
What this trial is testing

TMC278-TiDP6-C215: A Clinical Trial in Treatment Naive HIV-subjects Patients Comparing TMC278 to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors

Who this might be right for
HIV InfectionsHIV-1
Tibotec Pharmaceuticals, Ireland 680
Not applicableActive Not RecruitingNCT06773754
What this trial is testing

Fixed-Dose Combination of Bictegravir/Emtricitabine/Tenofovir Alafenamide Taken as 5 Days Per Week

Who this might be right for
Virally Suppressed People With HIV
National Taiwan University Hospital 60
Early research (Phase 1)Study completedNCT00002313
What this trial is testing

Nystatin in HIV-Infected Patients

Who this might be right for
HIV Infections
Argus Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT00822120
What this trial is testing

S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma

Who this might be right for
LymphomaNonneoplastic Condition
SWOG Cancer Research Network 371
Early research (Phase 1)Study completedNCT00001042
What this trial is testing

A Phase I, Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Compare the Safety and Immunogenicity of Recombinant Envelope Protein rgp120/HIV-1SF2 (BIOCINE) Combined With Seven Adjuvants in Healthy HIV-1 Uninfected Individuals

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 112
Not applicableStudy completedNCT00641641
What this trial is testing

The Effect of Raltegravir on HIV Decay During Primary and Chronic Infection

Who this might be right for
HIV Infection
Kirby Institute 16
Testing effectiveness (Phase 2)Study completedNCT00000823
What this trial is testing

Phase II Double-Blind Exploratory Study to Evaluate Differences Among Various Zidovudine/Didanosine Regimens on Quantitative Measures of Viral Burden in Relatively Early HIV-1 Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 85
Post-approval studies (Phase 4)UnknownNCT05147740
What this trial is testing

Study to Assess Switching to B/F/TAF in Treatment Experienced People With HIV Who Are at Least 65 Years of Age

Who this might be right for
HIV-1-infection
Tulika Singh, MD 50
Testing effectiveness (Phase 2)Study completedNCT00002210
What this trial is testing

Delavirdine Mesylate in Combination With Other Anti-HIV Drugs in HIV-Infected Children and Babies

Who this might be right for
HIV Infections
Pharmacia and Upjohn 24
Not applicableLooking for participantsNCT03603977
What this trial is testing

Simplified Treatment of Anti-retrovirus in China (C-STAR)

Who this might be right for
HIV/AIDS
Guangzhou 8th People's Hospital 600
Next Page